Table 3 Comparison of study initiation and intervention effects between clinics
Site | Study Initiation effect within each site | Relative-Risk between each site (p value)c | Chart Intervention effect within each site (p value)c | Relative-Risk between each site (p value)c | Total effect within each site (p value)c | Relative-Risk between each site and respective control site (p value)c | |
|---|---|---|---|---|---|---|---|
Viral Suppressiona | Bethesda CDC | 15·5% (0·022) | 1·03 (0·82) | −6·2% (0·42) | 0·86 (0·18) | 9·3% (0·12) | 0·89 (0·58) |
RK Khan (ref) | 13·8% (0·036) | 4·7% (0·01) | 18·6% (< 0·01) | ||||
Mkhuze | 28·3% (< 0·01) | 1·58 (0·03) | 10·9% (< 0·01) | 1·16 (< 0·01) | 39·3% (< 0·01) | 1·84 (< 0·01) | |
Shallcross (ref) | 14·7% (< 0·01) | 1·3% (0·49) | 16·0% (0·0) | ||||
Jozini | 29·2% (< 0·01) | 1·57 (< 0·01) | 7·0% (0·48) | 1·08 (0·55) | 36·2% (< 0·01) | 1·70 (< 0·01) | |
Township (ref) | 10·8% (< 0·01) | 0·7% (0·69) | 11·4% (< 0·01) | ||||
Viral Load Test Performedb | Bethesda CDC | 21·0% (< 0·01) | 1·08 (0·57) | −12·3% (0·05) | 0·82 (0·037) | 8·7%(0·16) | 0·88 (0·38) |
RK Khan (ref) | 16·4% (0·03) | 3·5% (0·42) | 19·9% (< 0·01) | ||||
Mkhuze | 31·2% (< 0·01) | 1·63 (0·03) | 10·7% (< 0·01) | 1·14 (< 0·01) | 41·9% (< 0·01) | 1·86 (< 0·01) | |
Shallcross (ref) | 13·8% (< 0·01) | 1·9% (0·34) | 15·7% (0·08) | ||||
Jozini | 27·9% (< 0·01) | 1·51 (0·01) | 9·0% (0·31) | 1·11 (0·43) | 37·1% (< 0·01) | 1·68 (< 0·01) | |
Township (ref) | 10·3% (< 0·01) | 1·8% (0·34) | 12·1% (0·01) |